1 – 15 of 74
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration
(
- Contribution to journal › Article
- 2018
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Diverse roles of cell-specific hypoxia-inducible factor 1 in cancer-associated hypercoagulation.
(
- Contribution to journal › Article
-
Mark
Metastasis stimulation by hypoxia and acidosis-induced extracellular lipid uptake is mediated by proteoglycan-dependent endocytosis
(
- Contribution to journal › Article
- 2015
-
Mark
Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.
(
- Contribution to journal › Article
-
Mark
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.
(
- Contribution to journal › Article
-
Mark
Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells.
(
- Contribution to journal › Article
- 2014
-
Mark
Glycosaminoglycans in cancer treatment.
(
- Contribution to journal › Article
-
Mark
APP/APLP2 expression is required to initiate endosome-nucleus-autophagosome trafficking of glypican-1-derived heparan sulfate.
(
- Contribution to journal › Article
-
Mark
Heparan sulfate proteoglycan as a cell-surface endocytosis receptor.
(
- Contribution to journal › Article